Last $35.74 USD
Change Today +0.54 / 1.53%
Volume 473.1K
As of 8:10 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at acorda therapeutics inc (ACOR)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Ron Cohen M.D.155 RelationshipsFounder, Chief Executive Officer, President and DirectorChief Executive Officer58

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Sandra Panem Ph.D. 54 RelationshipsMember of the Board of DirectorsCross Atlantic Partners, Inc.68
Steven Rauscher M.B.A. 28 RelationshipsMember of the Board of DirectorsOscient Pharmaceuticals Corp.60
Lorin Randall 72 RelationshipsMember of the Board of DirectorsYM BioSciences USA Inc.70
John Kelley MBA 37 RelationshipsMember of the Board of DirectorsTenax Therapeutics, Inc.60
Melitta Schachner Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Patrick Tresco Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Martin Grumet Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Stephen Waxman M.D., Ph.D. 28 RelationshipsMember of Advisory BoardMedlink Corporation--
Mary Bunge Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Mark Tuszynski M.D., Ph.D. 31 RelationshipsMember of Advisory BoardAlseres Pharmaceuticals, Inc.--
Carl Cotman Ph.D. 35 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.74
James Fawcett Ph.D. 31 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Michael Beattie Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Jerry Silver Ph.D. 43 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Mark Noble Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Jacqueline Breshnahan Ph.D. 20 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Eugene Johnson Jr., Ph.D. 46 RelationshipsMember of Advisory BoardAcorda Therapeutics, Inc.--
Barry Greene 41 RelationshipsMember of the Board of DirectorsAlnylam Pharmaceuticals, Inc.51
Ian Smith CPA, ACA 52 RelationshipsMember of the Board of DirectorsVertex Pharmaceuticals Incorporated48
Peder Jensen M.D. 40 RelationshipsMember of the Board of DirectorsFive Prime Therapeutics, Inc.60
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $35.74 USD +0.54

ACOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $38.14 USD 0.00
Biogen Idec Inc $414.13 USD +1.34
Depomed Inc $23.65 USD +0.66
Durect Corp $1.28 USD +0.03
Isis Pharmaceuticals Inc $70.16 USD +1.50
View Industry Companies
 

Industry Analysis

ACOR

Industry Average

Valuation ACOR Industry Range
Price/Earnings 84.7x
Price/Sales 3.6x
Price/Book 2.7x
Price/Cash Flow 84.8x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.